University Hospital, Basel, Switzerland: Substance-Related Disorders trials

The registry lists 11 Substance-Related Disorders studies with University Hospital, Basel, Switzerland as lead sponsor. 1 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 6No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Peer Education for Gender Inclusion and Substance Use in Southern AfricaRecruitingNCT06489899Not applicable
• Adherence to Polypharmacy in Patients With Opioid Substitution Therapy Using ElectronicsCompletedNCT02701660Not applicable
• PHAST: Physical Activity in Substitution TherapyCompletedNCT02309021Not applicable
• Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI StudyCompletedNCT01951508Early Phase 1
• Influence of Bupropion on the Effects of MDMACompletedNCT01771874Phase 1
• Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)CompletedNCT01386177Phase 1
• Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)CompletedNCT01270672Not applicable
• Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)CompletedNCT01136278Phase 1
• Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)CompletedNCT00990067Phase 1
• Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)CompletedNCT00895804Phase 1
• Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)CompletedNCT00886886Phase 1